CN105029628A - 一种少女减肥饮料 - Google Patents
一种少女减肥饮料 Download PDFInfo
- Publication number
- CN105029628A CN105029628A CN201510579042.XA CN201510579042A CN105029628A CN 105029628 A CN105029628 A CN 105029628A CN 201510579042 A CN201510579042 A CN 201510579042A CN 105029628 A CN105029628 A CN 105029628A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- fruit
- raw material
- maiden
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000012907 honey Nutrition 0.000 claims abstract description 18
- 244000241872 Lycium chinense Species 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 14
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 18
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 244000235858 Acetobacter xylinum Species 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 15
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 210000004072 lung Anatomy 0.000 abstract description 11
- 235000019640 taste Nutrition 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 235000005911 diet Nutrition 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 235000009508 confectionery Nutrition 0.000 abstract description 8
- 230000037213 diet Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 210000001124 body fluid Anatomy 0.000 abstract description 7
- 239000010839 body fluid Substances 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 5
- 230000018109 developmental process Effects 0.000 abstract description 5
- 230000011132 hemopoiesis Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 239000004519 grease Substances 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000007790 scraping Methods 0.000 abstract 1
- 239000013585 weight reducing agent Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 13
- 241001092040 Crataegus Species 0.000 description 10
- 208000008589 Obesity Diseases 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 235000020824 obesity Nutrition 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 241001247821 Ziziphus Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000031872 Body Remains Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- -1 oxygen radical Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Abstract
本发明公开了一种少女减肥饮料，原料由以下质量份：熟地6～10、枸杞子15～20、山药15～20、红枣15～20、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成；并公开了两种制备方法。本发明原料构成以促进身体发育、排毒养颜，润肺消积、生津益气为主，调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂为主，采用补消结合，日常饮用有益身体健康，健脾和胃，不影响饮食，排毒养颜、补肾润肺、生津益气，口感甘甜清香，适合少女生理需求，在饮食健身的同时达到了减肥的功效。
Description
技术领域
本发明涉及一种饮料，尤其涉及一种少女减肥饮料。
背景技术
减肥是以减少人体过度的脂肪、体重为目的的行为方式。指运用药物、饮食、运动、中医经络，心理疗法来达到减少身体脂肪堆积的一种现象，所有减肥方法均是直接或间接围绕热量为中心，有效指标为减少热量，健康指标为保护基础代谢，持续指标为食欲控制中的饱腹感和满足感。
目前的医学观点，肥胖算不上是疾病，却是许多人共同的烦恼。市面上有许多减肥的方法，比如，运动减肥，但却不是对每一个人都有效。有些人成功的减去了肥肉，不久精神松懈下来，人又胖了回去。
医学研究上同时认为，当人体内部缺少一种名为绿轻素的物质时，会导致人体血糖、脂肪及能量的调节紊乱，继而诱发并导致肥胖；当人体内的绿轻素浓度保持在正常水平时，人的体重便恢复正常。
从这些现象看来，显然现代医学对肥胖的病理研究还没有真正理清楚。现代医学对肥胖的理解是人体营养过剩时，身体会把多余的脂肪贮存在皮下，于是就造成了肥胖，也就是肥胖所增加的物质是脂肪，是一种被储存的能量。
少女一般指年轻未婚的女子。少女通常的年龄范围是12～18岁。妇科上，少女是特指13～17岁的姑娘。现阶段由于生活条件的提高，女孩子肥胖的越来越多，由于此阶段的女性仍然处于生长发育期，而且基本都是在校学习，因此，不合理的减肥会带来很多不良后果，如记忆力减退、身体虚弱、贫血等等影响了孩子的正常生理和身体发育，损伤身体，对一生的健康都不利，因此需要一种合理的方法来达到减肥的目的。
发明内容
本发明的目的在于克服现有技术中的不足，提供一种饮用口感好，不影响日常饮食，具有促进身体发育、排毒养颜，润肺消积、生津益气功效的少女减肥饮料。
为达到上述目的，本发明所采用的技术手段是：一种少女减肥饮料，原料由以下质量份：熟地6～10、枸杞子15～20、山药15～20、红枣15～20、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成。
进一步的，所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
更进一步的，取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
更进一步的，所述粉碎原料在放入容器中时加入茶叶。
进一步的，所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
更进一步的，所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。
更进一步的，所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
本发明的有益效果在于：原料构成以促进身体发育、排毒养颜，润肺消积、生津益气为主，调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂为主，采用补消结合，日常饮用有益身体健康，健脾和胃，不影响饮食，排毒养颜、补肾润肺、生津益气，口感甘甜清香，适合少女生理需求，在饮食健身的同时达到了减肥的功效。
具体实施方式
下面结合实施例对本发明做进一步的陈述。
实施例1
一种少女减肥饮料，原料由以下质量份：熟地8、枸杞子16、山药16、红枣18、荷叶10、山楂13、女贞子7、甘草14、蜂蜜27组成。
所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
操作时，我们可以将水烧开后，在烧水的水壶中自然冷却3分钟左右，水温自然冷却到92～95℃，将开水倒入茶壶或水杯中，将粉碎原料放入，盖上盖子使其缓慢冷却，自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。饮用的最佳水温是40度左右，当温度低于37度时，药效会下降。
饮用口感甘甜清香。可将茶叶依据个人口味在开水倒入茶壶或水杯中时放入，口感更佳，对减肥效果更好，但因为有许多人不喝茶叶，因此未在原料中加入茶叶。
实施例2
一种少女减肥饮料，原料由以下质量份：熟地7、枸杞子18、山药18、红枣19、荷叶11、山楂14、女贞子7、甘草13、蜂蜜30组成。
所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
在本实施例中，蜂蜜即是有效成分，起到调节血液、通便排毒的功能，又作为发酵能量。
发酵后口感与水泡的实施例1不同，味道酸甜清香。
实施例3
与实施例1或2不同之处在于：原料由以下质量份：熟地6、枸杞子15、山药15、红枣15、荷叶8、山楂10、女贞子5、甘草10、蜂蜜25组成。其制备方法采用实施例1或2的方法均可。
实施例4
与实施例1或2不同之处在于：原料由以下质量份：原料由以下质量份：熟地10、枸杞子20、山药20、红枣20、荷叶12、山楂15、女贞子8、甘草15、蜂蜜30组成。其制备方法采用实施例1或2的方法均可。
熟地：味甘，性温；归肝、肾经；功效：补血滋润，益精填髓；主治：血虚萎黄、眩晕心悸、月经不调、崩不止、肝肾阴亏、潮热盗汗、遗精阳痿、不育不孕、腰膝酸软、耳鸣耳聋、头目昏花、须发早白、消渴、便秘、肾虚喘促。
枸杞子：扶正固本和扶正怯邪，不但增强机体功能，促进健康恢复，而且能提高机体的抗病能力，抵御病邪的侵害。增强机体对各种有害刺激的适应能力。对癌细胞的生成和扩散有明显的抑制作用，治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症，能显著增加肌糖原、肝糖原的贮备量，提高人体活力，有抗疲劳的作用。改善大脑的功能，增强人的学习记忆能力。提高人体的适应性防御功能，使人遇到伤害性刺激时，如遇到缺氧、寒冷、失血等的忍耐承受能力。促进造血细胞增殖的作用，可以使白细胞数增多，增强人体的造血功能。有效地延缓衰老。提高皮肤吸收氧分的能力，起到美白作用。显著降低血清胆固醇和三酰甘油的含量，减轻和防止动脉硬化，治疗高血压。对过敏引起的胃肠道、关节疼出血等症状有缓解作用，这些作用是通过调节内分泌实现的。具有保肝补肾的作用，能抑制脂肪在肝细胞内沉积，并促进肝细胞的新生。枸杞子含有胍的衍生物，可以降低血糖，可以减轻体重，治疗肥胖症。枸杞子的有效成分枸橼酸甜菜碱具有治疗慢性肝炎、肝硬化等肝脏疾病的作用，有很好的疗效。
山药：味甘，性平；归肺、脾、肾经。补脾；养肺；固肾；益精。主脾虚泄泻；食少浮肿；肺虚咳喘；消渴；遗精；带下；肾虚尿频；外用治痈肿；瘰疬。有利于脾胃消化吸收功能，不论脾阳亏或胃阴虚，皆可食用。强健机体，滋肾益精的作用。大凡肾亏遗精、妇女白带多、小便频数等症，皆可服之。有降低血糖的作用。有效阻止血脂在血管壁的沉淀，预防心血疾病。取得益志安神，延年益寿的功效。
红枣：能提高人体免疫力，并可抑制癌细胞，能促进白细胞的生成，降低血清胆固醇，提高血清白蛋白，保护肝脏，红枣中还含有抑制癌细胞，甚至可使癌细胞向正常细胞转化的物质。枣中的维生素P含量为所有果蔬之冠，其具有维持毛细血管通透性，改善微循环从而预防动脉硬化的作用。还可以调节人体代谢、增强免疫力、抗炎、抗变态反应、降低血糖和胆固醇含量；所含芦丁有保护毛细血管通畅、防止血管壁脆性增加。大枣能提高体内单核细胞的吞噬功能，有保护肝脏、增强体力的作用；枣中的维生素C，能减轻化学药物对肝脏的损害，并有促进蛋白质合成，增加血清总蛋白含量，使体内多余的胆固醇转变为胆汁酸。对正在生长发育高峰的青少年和女性发生贫血有十分理想的食疗作用，其效果通常是药物不能比拟的。枣中的黄酮类物质可以防治脑缺血症并对脑缺血所致的脑组织超微结构损伤有保护作用。枣中含有丰富的维生素C、维生素P，对健全毛细血管、维持血管壁弹性，抗动脉粥样硬化很有益；枣中含有cAMP，其药理作用表现为改善人体微循环，扩张冠状动脉，增加脑和心脏的供血量，减慢心律，降低心肌耗氧量而改善缺血心肌的代谢，故可防治心脑血管病。对病后体虚的人也有良好的滋补作用。
荷叶：味苦辛微涩、性凉，归心、肝、脾经；清香升散；具有消暑利湿，健脾升阳，散瘀止血的功效；荷叶碱是荷叶中提取的生物碱，荷叶碱可扩张血管，清热解暑，有降血压的作用。荷叶是“药食两用”的食物，荷叶中富含的黄酮类物质，是大多数氧自由基的清除剂，可以提高SOD（超氧化物歧化酶）的活力，减少MDA（脂质过氧化物丙二醛）及0X－LDL（氧化低密度脂蛋白）的生成，它可以增加冠脉流量，对实验性心肌梗塞有对抗作用；对急性心肌缺血有保护作用；对治疗冠心病、高血压等有显著效果；对降低舒张压，防治心律失常、心血管病等也起重要作用。荷叶中的生物碱有降血脂作用，服用后在人体肠壁上形成一层脂肪隔离膜，有效阻止脂肪的吸收，从根本上减重，并更有效的控制反弹。
山楂：含有维生素C、胡萝卜素等物质能阻断并减少自由基的生成，能增强机体的免疫力，有防衰老、抗癌的作用；能消除体内脂肪、减少脂肪吸收，美颜瘦身。具有降压，降脂，抗氧化，增强免疫力，清除胃肠道有害细菌等，还可预防肝癌。能显著降低血清胆固醇及甘油三酯，有效防治动脉粥样硬化；还能通过增强心肌收缩力、增加心输出量、扩张冠状动脉血管、增加冠脉血流量、降低心肌耗氧量等起到强心和预防心绞痛的作用。此外，有扩张血管和持久降压的作用。具有活血化淤的作用，是血淤型痛经患者的食疗佳品。
女贞子：味甘、苦，性凉；归肝，肾经；功效：补肝肾阴，乌须明目，抑制幽门螺杆菌，可以治疗胃病，还具有抑制嘌呤异常代谢用于痛风和高尿酸血症。主治：用于肝肾阴虚，腰酸耳鸣，须发早白；眼目昏暗，视物昏暗；阴虚发热，胃病及痛风和和高尿酸血症。
甘草：性平，味甘，归十二经；有解毒、祛痰、止痛、解痉以至抗癌等药理作用。补脾益气，滋咳润肺，缓急解毒，调和百药。生用主治咽喉肿痛，痛疽疮疡，胃肠道溃疡以及解药毒、食物中毒等；蜜炙主治脾胃功能减退，大便溏薄，乏力发热以及咳嗽、心悸等。对组胺引起的胃酸分泌过多有抑制作用；并有抗酸和缓解胃肠平滑肌痉挛作用。甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用；祛痰作用也较显著。还有抗炎，抗过敏作用，能保护发炎的咽喉和气管粘膜。甘草里含有甘草素，是一种类似激素的化合物，它有助于平衡女性体内的激素含量。甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
蜂蜜：能改善血液的成分，促进心脑和血管功能，对肝脏有保护作用，能促使肝细胞再生，对脂肪肝的形成有一定的抑制作用。食用蜂蜜能迅速补充体力，消除疲劳，增强对疾病的抵抗力。还有杀菌的作用，不仅对牙齿无妨碍，还能在口腔内起到杀菌消毒的作用，能治疗中度的皮肤伤害，特别是烫伤，对胃肠功能有调节作用，可使胃酸分泌正常，增强肠蠕动的作用，可显著缩短排便时间。
对于肥胖的理解，发明人发现，形成肥胖的人会有气短、懒动等症状表现，在少女身上体现出的是乏力、不喜运动、嗜睡等，因此，发明人创造的使用了本发明的原料，对人体主导滋补、通便、排毒；以补益、排毒、增强机体功能、增强活力、调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂为主，采用补消结合，日常饮用有益身体健康，健脾和胃，不影响饮食，排毒养颜、补肾润肺、生津益气，口感甘甜清香，适合少女的生理需求，在饮食健身的同时达到了减肥的功效。
发明人认为，减肥必须找到问题的根本，不能单纯的依靠泄或超强运动，而应该在滋补身体，调节身体系统功能平衡上入手，通便排毒、生津益气、补肾润肺，增强活力，调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂，使肥胖人自身机能调整和消化，逐渐摆脱肥胖，身体强健有力，而不是变成消瘦的一个人，从一个极端走向另一个极端。
申请人通过分析后发现，实施例1和实施例2均能达到所需效果，但是具体区别在于，实施例1操作简单，而实施例2操作时间长，发酵过程控制要求高。实施例2通过发酵后，成分会有所改变，有益菌群增加，但药性强弱也会有变化，依据现有技术分析没有发现不利的问题。因此，申请人认为，实施例1的方式更适合个人操作，而实施例2更适合工业化生产。
本发明所公开的实施例只是对本发明技术方案的解释，并不作为对本发明的限制，凡是本领域技术人员在本发明基础上无创造性的替换，均在本发明的保护范围内。
Claims (7)
1.一种少女减肥饮料，其特征在于：原料由以下质量份：熟地6～10、枸杞子15～20、山药15～20、红枣15～20、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成。
2.根据权利要求1所述的少女减肥饮料，其特征在于：所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
3.根据权利要求2所述的少女减肥饮料，其特征在于：取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
4.根据权利要求3所述的少女减肥饮料，其特征在于：所述粉碎原料在放入容器中时加入茶叶。
5.根据权利要求1所述的少女减肥饮料，其特征在于：所述原料中熟地、枸杞子、山药、红枣、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
6.根据权利要求5所述的少女减肥饮料，其特征在于：所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。
7.根据权利要求6所述的少女减肥饮料，其特征在于：所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510579042.XA CN105029628A (zh) | 2015-09-14 | 2015-09-14 | 一种少女减肥饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510579042.XA CN105029628A (zh) | 2015-09-14 | 2015-09-14 | 一种少女减肥饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105029628A true CN105029628A (zh) | 2015-11-11 |
Family
ID=54437073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510579042.XA Pending CN105029628A (zh) | 2015-09-14 | 2015-09-14 | 一种少女减肥饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105029628A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211424A (zh) * | 1997-09-15 | 1999-03-24 | 王靖奇 | 降脂减肥散的药 |
| CN1481736A (zh) * | 2003-08-25 | 2004-03-17 | 保健饮品 | |
| CN101698028A (zh) * | 2009-11-03 | 2010-04-28 | 苏庆文 | 一种降脂减肥组合物及其制备方法 |
| CN102948563A (zh) * | 2012-11-27 | 2013-03-06 | 蒙思瑾 | 中药减肥保健茶 |
| CN103549052A (zh) * | 2013-07-18 | 2014-02-05 | 芜湖乐锐思信息咨询有限公司 | 一种美颜减肥茶及其制备方法 |
| CN104522243A (zh) * | 2014-12-25 | 2015-04-22 | 天津雪赢世纪专利技术有限公司 | 一种中药减肥保健茶 |
-
2015
- 2015-09-14 CN CN201510579042.XA patent/CN105029628A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211424A (zh) * | 1997-09-15 | 1999-03-24 | 王靖奇 | 降脂减肥散的药 |
| CN1481736A (zh) * | 2003-08-25 | 2004-03-17 | 保健饮品 | |
| CN101698028A (zh) * | 2009-11-03 | 2010-04-28 | 苏庆文 | 一种降脂减肥组合物及其制备方法 |
| CN102948563A (zh) * | 2012-11-27 | 2013-03-06 | 蒙思瑾 | 中药减肥保健茶 |
| CN103549052A (zh) * | 2013-07-18 | 2014-02-05 | 芜湖乐锐思信息咨询有限公司 | 一种美颜减肥茶及其制备方法 |
| CN104522243A (zh) * | 2014-12-25 | 2015-04-22 | 天津雪赢世纪专利技术有限公司 | 一种中药减肥保健茶 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
| CN107518133A (zh) | 一种解酒护肝花茶及其制备方法 | |
| CN104286273A (zh) | 铁皮石斛的用途及其茶叶制品 | |
| CN105341588A (zh) | 一种解酒护肝、保胃、清热润肺饮品及其制备方法 | |
| CN107873915A (zh) | 一种枸杞姜枣茶及其制备方法 | |
| CN108277138A (zh) | 一种保健养生酒及其制备方法 | |
| CN105878812A (zh) | 以金花茶-石斛为原料的解酒饮料及其生产方法 | |
| CN105077501A (zh) | 一种青年女性用减肥饮料 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN102100275A (zh) | 一种决明子茶 | |
| CN106509209A (zh) | 一种蜂胶保健茶及其制备方法 | |
| CN110522790A (zh) | 一种兼具抗疲劳、提高免疫力和除湿气功效的中药组合物及其制备方法和应用 | |
| CN105077449A (zh) | 一种少年男性减肥饮料 | |
| CN105796753A (zh) | 护肝中药组合物及其制备方法 | |
| CN108815015A (zh) | 一种眼膜及其生产工艺 | |
| CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
| CN103584244A (zh) | 清热润肺饮料其制备方法 | |
| CN106857937A (zh) | 一种具有辅助降血压功效的龙胆槐菊茶饮料 | |
| CN106806725A (zh) | 一种美容美白的桑葚面膜 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
| CN105265971A (zh) | 一种中年男性用减肥饮料 | |
| CN105029628A (zh) | 一种少女减肥饮料 | |
| CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
| CN105029627A (zh) | 一种青年男性用减肥饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |